The Role of Lactobacillus reuteri DSMZ17648 for Helicobacter pylori eradication therapy (Review of literature and advisory council resolution, February 28, 2018)

Aim of review. To analyze the options of application of Lactobacillus reuteri DSMZ17648 (Pylopass™) within Helicobacter pylori eradication. Summary. H. pylori eradication therapy is considered as one of the optional spheres for clinical application of probiotic medications. According to available da...

全面介紹

書目詳細資料

Principais autores:	V. T. Ivashkin, O. P. Alekseyeva, A. Yu. Baranovsky, Ye. K. Baranskaya, Ye. V. Beloborodova, T. A. Kolesov, N. V. Korochanskaya, K. . Lang, T. L. Lapina, I. V. Mayev, M. V. Mokshina, D. L. Nepomnyashchy, Ye. V. Onuchina, R. G. Sayfutdinov, T. H. Sviridova, V. I. Simanenkov, A. V. Tkachev, A. S. Trukhmanov, L. P. Faizova, I. B. Khlynov, O. B. Khlynova, A. A. Sheptulin
格式:	Artigo
語言:	Russo
出版:	Gastro LLC 2018-08-01
叢編:	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
主題:	lactobacillus reuteri пробиотик метабиотик helicobacter pylori
在線閱讀:	https://www.gastro-j.ru/jour/article/view/238
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!